Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006085 |
---|---|
Receipt number | R000007204 |
Scientific Title | A feasibility study of sequential Anthracycline-based regimen and Nab-Paclitaxel / Trastuzumab followed by Trastuzumab as postoperative adjuvant chemotherapy for Her2 positive breast cancer.(SBCCSG-22) |
Date of disclosure of the study information | 2011/08/01 |
Last modified on | 2018/12/18 20:10:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/07/31 16:14:49 | ||
2 | Update | 2014/01/31 18:26:57 | Email |
|
3 | Update | 2015/02/16 19:12:42 | Recruitment status Last follow-up date |
|
4 | Update | 2017/11/30 18:07:38 | UMIN ID1 |
|
5 | Update | 2018/12/18 20:10:30 | Recruitment status Last follow-up date |